NCT05011942

Brief Summary

Study objectives include assessing the use of Irrisept irrigation solution in lumbar spinal fusion procedures and effect on clinical and patient reported outcome measures. This includes assessing postoperative SSI as well as fusion rates in addition to patient reported outcome measures.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 18, 2021

Completed
10 months until next milestone

Study Start

First participant enrolled

June 6, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

2.5 years

First QC Date

July 30, 2021

Last Update Submit

September 6, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Postoperative surgical site infections

    Postop SSI

    assessed for change at 1 month

  • Postoperative surgical site infections

    postop SSI

    assessed for change at 3 months

  • Postoperative surgical site infections

    postop SSI

    assessed for change at 6 months

  • Postoperative surgical site infections

    postop SSI

    assessed for change at 12 months

Secondary Outcomes (16)

  • Fusion rates after surgery

    assessed at 1 month

  • Fusion rates after surgery

    assessed for change at 3 months

  • Fusion rates after surgery

    assessed for change at 6 months

  • Fusion rates after surgery

    assessed for change at 12 months

  • Patient outcome measures

    assessed at 1 month

  • +11 more secondary outcomes

Study Arms (2)

normal saline control arm

PLACEBO COMPARATOR

ii. normal saline used after initial skin incision prior to coming through fascia, after placement of instrumentation (screws, hooks), prior to placement of bone graft, and after fascial closure iii. Irrigation exposure/soak time to be 1 min for each irrigation time point.

Device: Irrisept Irrigation solution

Irrisept irrigation solution

ACTIVE COMPARATOR

ii. Irrigation (Irrisept vs control of normal saline) used after initial skin inicision prior to coming through fascia, after placement of instrumentation (screws, hooks), prior to placement of bone graft, and after fascial closure iii. Irrigation exposure/soak time to be 1 min for each irrigation time point. iv. 1 bottle (450 mL) Irrisept irrigation to be used during case with normal saline rinse to follow at each irrigation time point in study subjects

Device: Irrisept Irrigation solution

Interventions

ii. Irrigation (Irrisept vs control of normal saline) used after initial skin inicision prior to coming through fascia, after placement of instrumentation (screws, hooks), prior to placement of bone graft, and after fascial closure iii. Irrigation exposure/soak time to be 1 min for each irrigation time point. iv. 1 bottle (450 mL) Irrisept irrigation to be used during case with normal saline rinse to follow at each irrigation time point in study subjects v. Normal saline irrigation will be used alone in control subjects at the same time points.

Irrisept irrigation solutionnormal saline control arm

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-85, undergoing primary lumbar spinal fusion (less than or equal to 3 levels)

You may not qualify if:

  • Prior lumbar fusion (decompression only okay), spinal infection, spinal neoplasm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Kansas Medical Center

Kansas City, Kansas, 66106, United States

Location

MeSH Terms

Conditions

Spinal Diseases

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: This is a randomized 1:1 treatment of placebo or standard of care irrigation and Irrisept solution.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2021

First Posted

August 18, 2021

Study Start

June 6, 2022

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations